Cardiovascular Risk Factors After Renal Transplantation in Children and Adults (HENT)
Recruitment status was: Active, not recruiting
Renal transplantation of children started in Norway in 1970.Since the beginning, >80% of renal transplants are provided from Living Donors(mainly parents), short pre-transplant dialysis time( median 4 months) and 50% of transplantations are performed before dialysis is needed.This gives good premises for graft survival and avoidance of detrimental effects of dialysis. However, renal transplanted children are subjected to an increased cardiovascular morbidity and mortality in adulthood due to consequences of chronic renal failure and immunosuppressive treatment.Cardiovascular death comprises 30-40% of death causes. In this cross-sectional study we evaluate cardiovascular risk factors in childhood- and also in young adults renal transplanted in childhood.
Focus is cardiorespiratory fitness using treadmill testing,24h BP measurements, anthropometrics including waist circumference,echocardiography,intima media thickness of carotids, glucose intolerance test.Participants are also requested to fill out physical activity recalls and Quality of life questionnaires.
Overweight and Obesity
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||Outcome After Pediatric Renal Transplantation: Cardiorespiratory Fitness, Cardiovascular Risk Factors and Quality of Life|
- other cardiovascular risk factors [ Time Frame: 2007-2010 ]
- hypertension [ Time Frame: 2007-2010 ]
- impaired glucose intolerance [ Time Frame: 2007-2010 ]
- left ventricular hypertrophy, [ Time Frame: 2007-2010 ]
Biospecimen Retention: Samples Without DNA
|Study Start Date:||June 2007|
|Estimated Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
Renal transplanted children and young adults
Renal transplanted children and adolescents (2-18yrs) transplanted between 1993-2006.
Renal transplanted young adults aged 20-35 yrs old, transplanted from 1983 onwards.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01008306
|Oslo University Hospital Rikshospitalet HF, Division of Pediatrics|
|Oslo, Norway, 0027|